Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma

Academic Article

Abstract

  • One hundred four patients with advanced colon carcinoma were treated with mitoxantrone 5 mg/m2 I.V. weekly. The patients were stratified into two groups: prior chemotherapy and no prior chemotherapy. Only one partial response was noted in the prior treatment category.
  • Digital Object Identifier (doi)

    Author List

  • DeSimone PA; Gams R; Bartolucci A
  • Start Page

  • 517
  • End Page

  • 522
  • Volume

  • 7
  • Issue

  • 5